Molson Coors Beverage Company TAP has posted fourth-quarter 2024 results, wherein the top and bottom lines beat the Zacks ...

Molson Coors (NYSE:TAP) sailed past consensus estimates with its Q4 earnings report and set a favorable outlook. Financial volume decreased 6.4% during the quarter, primarily due to lower shipments in ...

Full-year sales reached $26.8 billion, driven by robust performance across HIV, oncology, and liver disease portfolios. HIV sales grew 8% year-over-year to $19.6 billion in 2024, exceeding ...